Landsberg Bennett & Dubbaneh’s DexCom DXCM Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4.66M	Sell	33,880 -600	-2%	-$75.7K	0.59%	47
2021 Q2	$3.68M	Buy	34,480 +1,804	+6%	+$173K	0.48%	60
2021 Q1	$2.99M	Buy	32,676 +6,480	+25%	+$608K	0.43%	71
2020 Q4	$2.42M	Buy	26,196 +7,236	+38%	+$646K	0.37%	79
2020 Q3	$1.91M	Buy	18,960 +412	+2%	+$43K	0.33%	84
2020 Q2	$1.85M	Sell	18,548 -4,908	-21%	-$439K	0.38%	73
2020 Q1	$1.56M	Buy	23,456 +2,140	+10%	+$133K	0.44%	61
2019 Q4	$1.15M	Buy	21,316 +176	+0.8%	+$8.35K	0.27%	104
2019 Q3	$785K	Sell	21,140 -1,260	-6%	-$49K	0.21%	107
2019 Q2	$848K	Buy	22,400 +7,576	+51%	+$238K	0.22%	108
2019 Q1	$436K	Buy	14,824 +140	+1%	+$4.92K	0.1%	162
2018 Q4	$440K	Buy	+14,684	New	+$466K	0.17%	141

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's DXCM Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its DexCom (DXCM) stake by 1.7% in Q3 2021, selling an estimated $75.7K and leaving 33,880 shares worth $4.66M. The position accounts for 0.59% of the portfolio, ranked #47.

Landsberg Bennett & Dubbaneh first reported a position in DXCM in Q4 2018 and has held it in 12 quarters since. 796 funds tracked by Wall St. Rank hold DXCM as of Q3 2021.

Landsberg Bennett & Dubbaneh held 33,880 shares of DexCom worth $4.66M as of Q3 2021.
Landsberg Bennett & Dubbaneh sold 600 DexCom shares in Q3 2021, an estimated $75.7K.
DexCom made up 0.59% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #47 holding.
Landsberg Bennett & Dubbaneh first reported a position in DexCom in Q4 2018 and has held it in 12 quarters since.
796 funds tracked by Wall St. Rank held DexCom as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.